Vimarsana
Biggest News Aggregation in the World

Page 25 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

PHATHOM PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Vimarsana News

PHATHOM PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events. On May 23, 2023, Phathom Pharmaceuticals, Inc. entered into an underwriting agreement with Jefferies LLC and Evercore Group L.L.C., as representatives of the... | June 11, 2023

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock - Vimarsana News

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock

FLORHAM PARK, N.J., May 23, 2023 -- Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced... | May 23, 2023

The Vita Coco Company, Inc. Announces Secondary Offering of Common Stock by Selling Stockholder - Vimarsana News

The Vita Coco Company, Inc. Announces Secondary Offering of Common Stock by Selling Stockholder

NEW YORK, May 22, 2023 -- The Vita Coco Company, Inc. , a leading high-growth platform of better-for-you beverage brands, today announced that an existing stockholder, Verlinvest Beverages SA... | May 22, 2023

Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares - Vimarsana News

Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares

PHILADELPHIA, May 22, 2023 -- Cabaletta Bio, Inc. , a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with... | May 22, 2023

AIG to Sell Validus Re to RenaissanceRe - Vimarsana News

AIG to Sell Validus Re to RenaissanceRe

Divestiture of AIG’s Treaty Reinsurance Business Continues Progress on AIG’s Portfolio Repositioning, Reduces Volatility in Underwriting Results, Accelerates Focus on Insurance Business,... | May 22, 2023